https://www.neurologylive.com/view/mechanistic-potential-synapse-targeted-agent-alx-001-alzheimer-adam-mecca
The associate director of the Alzheimer’s Disease Research Unit at the Yale School of Medicine discussed the mechanism of action of ALX-001, a highly selective agent in development for neurodegenerative diseases. [WATCH TIME: 5 minutes]
Create an account or login to join the discussion